Straits Times Index
3,330.81 +0.80 (+0.02%) S&P 500
5,355.67 +1.64 (+0.03%) Dow
38,955.92 +148.59 (+0.38%) Nasdaq
17,161.29 -26.62 (-0.15%) Bitcoin USD
71,107.76 +684.58 (+0.97%) CMC Crypto 200
1,519.94 -4.86 (-0.32%)
EW Nov 2024 80.000 call
- Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
- Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
- Simply Wall St.
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
